370 related articles for article (PubMed ID: 4944283)
1. The future of transplantation biology and medicine.
Medawar P
Transplant Proc; 1969 Mar; 1(1):666-9. PubMed ID: 4944283
[No Abstract] [Full Text] [Related]
2. Some critical remarks and suggestions about antilymphocyte serum.
Grabar P
Transplant Proc; 1972 Sep; 4(3):407-13. PubMed ID: 4628101
[No Abstract] [Full Text] [Related]
3. Non-specific and adaptive immunity in renal transplantation.
Alexander JW; McCoy HV; Phair JP; Altemeier WA
Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
[No Abstract] [Full Text] [Related]
4. [Antilymphocyte sera in experimental and clinical medicine].
Kaden J
Dtsch Gesundheitsw; 1972 Feb; 27(6):241-7. PubMed ID: 4622789
[No Abstract] [Full Text] [Related]
5. Heart transplantation: clinical and experimental progress.
Goldman BS
Can J Surg; 1973 Nov; 16(6):351-9. PubMed ID: 4594096
[No Abstract] [Full Text] [Related]
6. [Immunological supervision and carcinogenesis].
Gorelik LS
Usp Sovrem Biol; 1975; 80(2):270-86. PubMed ID: 55009
[No Abstract] [Full Text] [Related]
7. [Immunological problems in organ transplantation (with reference to oncology)].
Gazzera G
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(9):599-614. PubMed ID: 4932115
[No Abstract] [Full Text] [Related]
8. Serum antithymocyte globulin (ATG) and anti-ATG levels in cardiac recipients.
Bieber CP; Oyer PE; David L; Griepp RB; Stinson EB
Surg Forum; 1974; 25(0):285-7. PubMed ID: 4612778
[No Abstract] [Full Text] [Related]
9. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum.
Donawick WJ; Shaffer CF; Dodd DC; Buchanan JW; Fregin GF
Transplant Proc; 1971 Mar; 3(1):551-3. PubMed ID: 4937937
[No Abstract] [Full Text] [Related]
10. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
Monaco AP; Franco DJ
Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
[No Abstract] [Full Text] [Related]
11. Mechanism for prolonged survival of pig renal allografts.
Perper RJ; Bowersox BE; Van Gorder TJ
Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451
[No Abstract] [Full Text] [Related]
12. Transfer factor, homograft rejection and the effects of antilymphocyte serum in man.
Lawrence HS
Fed Proc; 1970; 29(1):183-5. PubMed ID: 4904622
[No Abstract] [Full Text] [Related]
13. Effect of immunosuppression and cellular antigen on xenograft survival.
Cerilli J; Gideon L; Hattan D
Transplant Proc; 1970 Dec; 2(4):516-21. PubMed ID: 4939699
[No Abstract] [Full Text] [Related]
14. The mechanism of action of heterologous anti-lymphocyte sera. I. "In vitro" activity and their effects on different aspects of immunity in rats.
Kahan A; Jouanneau M; Brouilhet H; Delbarre F; Charles A
Biomedicine; 1973 Jan; 18(1):69-77. PubMed ID: 4576461
[No Abstract] [Full Text] [Related]
15. [Immunosuppressive agents].
Pelletier G
Laval Med; 1970 Nov; 41(11):1156-60. PubMed ID: 4394730
[No Abstract] [Full Text] [Related]
16. Early, low dose rabbit ALG therapy in cadaver kidney transplantation.
Mannick JA; Nabseth DC; Olsson CA; Davis RC
Transplant Proc; 1972 Dec; 4(4):497-9. PubMed ID: 4566794
[No Abstract] [Full Text] [Related]
17. Experimental kidney transplantation.
Skośkiewicz M; Rowiński W
Pol Med J; 1971; 10(2):455-8. PubMed ID: 4934235
[No Abstract] [Full Text] [Related]
18. [Antilymphocyte serum (ALS) as immunosuppressive agent].
Piardi W
Folia Allergol (Roma); 1971; 18(1):27-68. PubMed ID: 4397372
[No Abstract] [Full Text] [Related]
19. Immunosuppressive chemotherapy and malignancy.
Schwartz RS
Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
[No Abstract] [Full Text] [Related]
20. [Effect of heterologous antilymphocyte serum on the immunoreactivity of mice].
Andreson RK
Biull Eksp Biol Med; 1970 Mar; 69(3):84-7. PubMed ID: 4928082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
